Mumbai, September 18, 2023: Multispecialty Hospital Chain, Jupiter Life Line Hospitals Limited debuted on the exchanges at 32.38% premium.
The scrip listed Rs. 960.00 per share on BSE and Rs. 973.00 per share on NSE, at a premium of 30.61% and 32.38% respectively. The company's share price closed at Rs. 1,075.25 per share on the BSE, a 46.29% premium, and at Rs. 1,073.95 per share on the, 46.11% premium.
As per NSE, the total quantity traded stood at 128 lakh shares, on BSE the total Quantity stood at 8.5 lakh shares. Total Turnover (BSE+NSE) on Day 1 stood at Rs 1,406.46 crore.
The Market Capitalization of the Company at today’s closing price stood at Rs. 7,049.99 Crore as per BSE and Rs. 7,041.46 Crore as per NSE.
Led by founder, Chairman and Managing Director, Dr. Ajay P Thakker with over 3 decades of experience in the field of medicine and healthcare and Dr. Ankit Thakker, Executive Director and Chief Executive Officer who has a more than a decade experience in the healthcare sector. The Company commenced operations in 2007 with a hospital in Thane, Maharashtra and has been operating for over 15 years as a corporate quaternary care healthcare service provider in the western regions of India. It currently operates three hospitals in Thane, Pune and Indore under the “Jupiter” brand.
Jupiter Hospitals has a strategic focus on the western India healthcare market. It currently is in the process of developing a multispecialty hospital in Dombivli, Maharashtra, which is being designed to accommodate over 500 beds. The construction of the hospital began in April 2023 and will be spread across 600,000 sq. feet.